NCT04910477View on ClinicalTrials.gov

Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 3, 2021

Conditions
Postdural Puncture Headache
Interventions
DRUG

Dexmedetomidine

ultrasonic nebulization of dexmedetomidine (1 mg/kg diluted in 4 mL saline) twice daily for three days.

DRUG

Neostigmine/atropine

nebulization of 20 µ/kg neostigmine and 10 µ/kg atropine mixed in 4 ml) twice daily for three days.

OTHER

Saline placebo

nebulization of saline placebo in 4 ml) twice daily for three days.

Trial Locations (1)

Assuit universi

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER